Petadolex Butterbur Gelcaps Helps Greatly Reduce Migraines

New All-Natural Drug Petadolex Butterbur Gelcaps Helps Greatly Reduce Migraine Episodes Presented at American Headache Society Meeting

A new, all-natural drug, prescribed for years throughout Europe, offers migraine sufferers a solution. Debilitating onsets of migraine headaches affect 23 to 26 million Americans, causing partial vision loss, nausea, sensitivity to light and noise, and an inability to function at work and home. Migraine headaches cost the United States economy over $11 billion each year in terms of lost workdays.

Petadolex Butterbur Gelcaps, which has ingredients extracted from the Butterbur plant, is a prophylactic drug manufactured by Weber & Weber that helps migraine sufferers prevent the onset of the incapacitating headaches. Weber & Weber is a German-based pharmaceutical manufacturer started in Germany in 1953. Since the company’s founding, it has grown and expanded to the United States.

German companies have long been known as the world’s leader in herbal remedies, having operated for decades under stringent government regulations.

Conventional drugs are often prescribed by physicians to alleviate the symptoms caused by migraine, but many times are very expensive, have severe side effects, and sometimes are not effective.

For years, migraine sufferers have been searching for alternatives to alleviate their headache pain through lifestyle changes in diet, exercise, stress reduction and increased sleep. Other options sufferers look to are all-natural products found in plants, minerals and animals – a homeopathic approach.

Patients take one 50 mg tablet twice daily of Petadolex Butterbur Gelcaps for a minimum of four weeks before preventative effects can be seen. The drug is designed to lower the frequency and pain intensity of migraines, not treat the acute conditions associated with migraine. Petadolex Butterbur Gelcaps should be taken as a part of phytopharmaceutical migraine therapy.

Petadolex Butterbur Gelcaps has been tested and used in Europe for many years, and is very popular. In 1996, Werner Grossman, MD, a professor at the University of Munich in the department of Neurology and Pharmacology in Germany, conducted a double-blind study of Petadolex Butterbur Gelcaps. The study, carried out in strict accordance with standards established by the International Headache Society and Good Clinical Practice, compared Petadolex Butterbur Gelcaps use to a placebo.

Results indicate that the Petadolex Butterbur Gelcaps group had significantly fewer attacks, fewer migraine days, less pain intensity and shorter duration of attacks than those taking the placebo. The study revealed that the drug has no known side effects. An American trial is underway with promising results expected by year-end. Alexander Mauskop, MD, submitted an abstract in the May, 2000 issue of the journal Headache, Vol 40; Issue 5; pg 420. American Headache Society President Richard Lipton, MD concurs with the findings. “Petadolex Butterbur Gelcaps is a promising new preventative strategy for migraine sufferers,” he states.

The Journal of the American Medical Association (November 11, 1998 – Vol. 280, No. 18) reported that use of at least one to 16 alternative therapies during the previous year (of the study) increased from 33.8 percent in 1990 to 42.1 percent in 1997. Overall use of alternative therapies increased from 1990 to 1997 by 25 percent, total visits by an estimated 47 percent, and expenditures on services provided by practitioners of alternative therapies by an estimated 45 percent.

The journal reports that 12.1 percent of respondents used herbal medicine in the past year (of the study), an increase from 2.5 percent in 1990. Also noted is that in the past year of the study, 3.4 percent stated that they used homeopathy, an increase of 0.7 percent in 1990. One of the most common uses for alternative therapy in those studied was headache.

Because Americans are beginning to seek alternative therapies and herbal remedies more aggressively, Weber & Weber offers its all-natural migraine medication Petadolex Butterbur Gelcaps to American consumers through select pharmacies, health food stores and the company’s web site. For more information on Petadolex Butterbur Gelcaps and Weber & Weber, please visit booth 8 at the American Headache Society meeting,


Previous Post

New Evidence 1998 Butterbur a Natural Solution to Migraine

Next Post

Migraine Sufferers Now Have Safe, New Options for Relief

Leave a Reply